Image

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

The present study aims to evaluate the modification of functional capacity induced by an adapted physical activity program in subjects with haemophilia.

The exercise program used aims to improve joint mobility, muscle strength, static and dynamic balance, motor coordination.

The program is structured in 1 hour sessions of 2 days/week and lasts 6 months.

The primary endpoint is the change in functional capacity calculated as the difference between the baseline assessment and the 3 and 6 month assessment of the 6 Minutes Walking Test measured with the G-Walk (BTS Bioengineering S.p.A).

Eligibility

Inclusion Criteria:

  • Diagnosis of hemophilia A or B;
  • Signature of informed consent;
  • Availability of a medical certificate for non-competitive activities

Exclusion Criteria:

  • Active bleeding
  • Severe joint deformities that prevent exercise
  • Insufficiency of communicative and/or sensory functions so severe that it is impossible to understand or carry out the trainer's instructions (dementia, aphasia, blindness, deafness)
  • Heart failure (NYHA class > 2)
  • Unstable angina
  • Lung disease requiring oxygen therapy
  • Symptomatic peripheral arterial disease
  • Myocardial infarction or hospitalization within the previous 6 months
  • Symptomatic orthostatic hypotension
  • Hypertension in poor pharmacological control (diastolic> 95 mmHg, systolic> 160 mmHg)
  • Significant neurological conditions that impair motor or cognitive function

Study details
    Hemophilia
    Sports Physical Therapy

NCT06580340

Istituto Ortopedico Rizzoli

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.